Company: NYXH
Filing Date: 2025-03-20
Form Type: F-3
Source: 0001104659-25-026217
Chunk: 64

Company: Nyxoah SA
Filing Date: 2025-03-20
Form: F-3
Chunk 64
---
 to us as of the date of such documents. We disclaim any intent to update any forward-looking statements.

#### Risks Related to This Offering
Our management will have broad discretion over the use of the net proceeds from this offering, and you may not agree with how we use the proceeds and the proceeds may not be invested successfully.

Our management will have broad discretion as to the use of the net proceeds from this offering and could use them for purposes other than those contemplated at the time of this offering. Accordingly, you are relying on the judgment of our management with regard to the use of these net proceeds, and you will not have the opportunity, as part of your investment decision, to assess whether the proceeds will be used appropriately. It is possible that the proceeds will be invested in a way that does not yield a favorable, or any, return for Nyxoah.

Purchasers may experience immediate dilution in the book value per ordinary share of the ordinary shares purchased in the offering.

The ordinary shares represented by ordinary shares sold in this offering, if any, will be sold from time to time at various prices. However, we expect that the offering price of our ordinary shares will be substantially higher than the net tangible book value per ordinary share, and per each underlying ordinary share, prior to this offering. After giving effect to the sale of ordinary shares stock in the aggregate amount of $50.0 million at an assumed offering price of $10.60 per ordinary share, the last reported sale price of our ordinary shares on March 18, 2025 on The Nasdaq Global Market, and after deducting commissions and estimated offering expenses, our as adjusted net tangible book value as of December 31, 2024 would have been $113.1 million, or $2.68 per ordinary share. This represents an immediate increase in net tangible book value of approximately $0.94 per ordinary share to our existing shareholders and an immediate dilution in as adjusted net tangible book value of $7.92 per ordinary share to purchasers of ordinary shares in this offering.

You may experience future dilution as a result of future equity offerings.

In order to raise additional capital, we may in the future offer additional of our ordinary shares or other securities convertible into or exchangeable for our ordinary shares. We cannot assure you that we will be able to sell ordinary shares or other securities in any other offering at a price per ordinary share that is equal to or greater than the price per ordinary share paid by investors in this offering, and investors purchasing ordinary shares